Table 3.

Proportions of patients found to have in active disease according to notable baseline clinical characteristics.

Baseline Characteristic	Inactive Disease at 1 year	Inactive Disease ever
Active enthesitis	7/28 (25%)	14/36 (39%)
No active enthesitis	29/60 (48%)	53/89 (60%)
p value	0.04	0.04
CHAQ < 1	31/58 (53%)	47/76 (62%)
CHAQ ≥ 1	5/23 (22%)	11/30 (37%)
p value	0.01	0.02
Normal ESR	13/40 (33%)	26/58 (45%)
Elevated ESR	10/23 (43%)	19/29 (66%)
p value	0.4	0.07
Initiate TNF-α inhibitor ≤ 6 months after diagnosis	18/45 (40%)	35/61 (57%)
Initiate TNF-α inhibitor > 6 months after diagnosis	18/43 (42%)	32/64 (50%)
p value	0.9	0.4

(CHAQ, Childhood Health Assessment Questionnaire; TNF-α, tumor necrosis factor alpha)